Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- How to Price of Innovative Drugs to Be Major Issue in FY2003: Mr Fujiyama of FPMAJ
March 17, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
March 17, 2003
- Industry FTC Outlines Stricter Measures to Prevent Code Violations
March 17, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
March 17, 2003
- Fukujin Aims at Group Sales of \1 Trillion in 2006
March 17, 2003
- OUA 3rd Academic Meeting Held
March 17, 2003
- Toho Determined to Reach Price Accord by End of March
March 17, 2003
- Deregulation WG Clashes with Korosho in OTC Sale
March 17, 2003
- OPMA to Reorganize Its Structure
March 17, 2003
- AJD to Expand Activities of Home Medication Kyokai
March 17, 2003
- Drug-related Patent Applications Up Sharply in 2002: Patolis Survey
March 17, 2003
- OTC NEWS IN BRIEF
March 17, 2003
- BUSINESS NEWS IN BRIEF
March 17, 2003
- ITX Aims for Sales of \8 bil. in Life Science Business by FY2006
March 17, 2003
- NEW PRODUCTS
March 17, 2003
- Shimadzu Acquires Non-exclusive License to Eiken's LAMP Method for Animal Disease
March 17, 2003
- Donepezil, Rabeprazole Going on Strong Growth: Mr Naito of Eisai
March 17, 2003
- 10 Contract Lab Test Centers Excluded from Nominative Tenders
March 17, 2003
- Approval of Aventis Pharma's Arava, GSK's Imigran Recommended
March 17, 2003
- DIAGNOSTIC NEWS IN BRIEF
March 17, 2003
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…